LONDON - Ark Therapeutics plc raised £27.1 million (US$49.5 million) in a placing and open offer, reinforcing its cash position and providing the resources to get two gene therapy products to commercialization, along with a third product for treating cancer cachexia. (BioWorld International) Read More
